top of page


FDA approves Nuedexta which was discovered at CNS and developed by Avanir pharmaceutical corporation.

November 5, 2011 – Dr. Smith spoke at Neurology grand rounds at Stanford.

June 27-28, 2011 – At the California ALS Summit, held in San Francisco, Dr. Smith gave a talk entitled "The ALS phenotype: lost in translation" and chaired a session dealing with molecular therapy for ALS.

October 1, 2011 – This presentation, titled "Developing therapeutics for amyotrophic lateral sclerosis," to ALS patients/families, sponsored by the ALS association, was made by Dr. Smith in connection with the 2011 California ALS summit.

March 2010 – Dr. Smith gave a series of lectures at UFM in Guatemala city

April 14, 2010 – Dr. Smith spoke at the annual meeting of the American Academy of Neurology.

bottom of page